Pharmacodynamic Assessment of Ertapenem (MK-0826) against Streptococcus pneumoniae in a Murine Neutropenic Thigh Infection Model

The objective of this study was to determine the susceptibility breakpoint of a new carbapenem, ertapenem (MK-0826), against Streptococcus pneumoniae strains based on bacterial density and survival studies in a murine thigh infection model. Sixteen S. pneumoniae isolates for which MICs ranged from 0...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Xuan, Dawei, Banevicius, Maryanne, Capitano, Blair, Kim, Myo-Kyoung, Nightingale, Charles, Nicolau, David
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2002
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127426/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12183258/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.9.2990-2995.2002
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!